COS-10 Clinical Update: Pediatrics

ROP, Paediatric Ocular Oncology

Friday June 29, 2012, 1045-1215
Metro West

Objectives
At the end of this session, participants will be able to:

  • Describe current concepts on the presentation, diagnosis and treatment of some intra and extra-ocular tumors that affect children.
  • Critically evaluate the ophthalmic and systemic aspects of anti-VEGF therapy for ROP and to compare the impact the advent of such therapy has had in the practice of pediatric ophthalmologists in North America.

Moderator
Elise Héon

1045Introduction
Elise Héon
1048A new presentation of cherry red spot in infant botulism
Naveen Mysore, Sheila Huang, Ayesha Khan, Robert K. Koenekoop
1055Discussion
1102Website update 2012-Pediatric and adult strabismus: an online information resource
Michael Flanders
1109Discussion
1114The rare case of optic nerve glioma with intraocular seeding in a child with Neurofibromatosis Type 1 (NF-1)
Vasudha Gupta, Kaitlyn Whelan, Kourosh Sabri
1121Discussion
1126Change in vision as a result of chemotherapy in children with optic pathway gliomas
Evan Kalin-Hajdu, Monia Marzouki, Jean-Claude Decarie, Anne-Sophie Carret, Albert Labrisseau, Linda Hershon, Ellen Freeman, Luis H. Ospina
1133Discussion
1138Utilization of anti-VEGF agents in retinopathy of prematurity (ROP): Results of a North American survey
Kamiar Mireskandari, Megan E. Collins, Nasrin N. Tehrani
1145Discussion
1150An update on the Seminal Canadian Recommendations for Evidence based Examination of Neonates for ROP (SCREEN-ROP) study
Kourosh Sabri, Sandesh Shivananda, Forough Farrokhyar, Kaitlyn Whelan, Wendy Seidlitz, Anna Ells, Shoo Lee, Canadian Neontal Network
1157Discussion
1215CAPO business meeting - Pier 8